06:25 EDT Actuate Therapeutics (ACTU) files to sell 3.9M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on ACTU: Actuate Therapeutics: Promising Phase 2 Results and Market Potential for Elraglusib in Metastatic Pancreatic Cancer Actuate Therapeutics initiated with a Buy at H.C. Wainwright Actuate Therapeutics completes enrollment in Phase 2 trial of elraglusib Disclaimer & DisclosureReport an Issue
